Legal Representation
Attorney
ALLEN E. WHITE
USPTO Deadlines
Application History
7 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 10, 2008 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Dec 10, 2008 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| May 14, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN |
| May 14, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED |
| May 14, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 30, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 29, 2008 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of elevated circulating cholesterol, vascular inflammation, atherosclerosis, cardiovascular disease, diabetes mellitus, infection and/or inflammation in immunosuppressed subjects, cancer, organ transplant rejection and graft-versus-host-disease, bacteremia, sepsis, septic shock, Acute Respiratory Distress Syndrome, pain, wounds, respiratory disorders, neurofibromatosis, rheumatoid arthritis, Waginer's granulomatosis, Kawasaki's disease, lupus erathematosis, midline granuloma, inflammatory bowel disease, osteoarthritis, leiomyomas, adenomas, lipomas, hemangiomas, fibromas, vascular occlusion, restenosis, pre-neoplastic lesions, carcinoma in situ, oral hairy leukoplakia, psoriasis, pre-leukemias, anemia with excess blasts, and myelodysplastic syndrome
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO